International Journal of Drug Policy

Article	Citations
Quasi-experimental study on the impact of local smoke-free policies on smoking among Indonesian adults: Evidence from repeated national health surveys	196
A content analysis of cannabis edibles package marketing in the United States	119
Co-designing the INHSU Prisons Hepatitis C Advocacy Toolkit using the Advocacy Strategy Framework	113
Bridging the gap: An environmental scan of post-overdose program features and evaluation measures	90
Illicit drug prices and quantity discounts: A comparison between a cryptomarket, social media, and police data	69
Shifting awareness among electronic dance music party attendees that drugs may contain fentanyl or other adulterants	64
‘Choice’ of social media platform or encrypted messaging app to buy and sell illegal drugs	64
Opioid prescribing restrictions and opioid use among the Louisiana Medicaid population	63
International property rights for Cannabis landraces and terroir products. The case of Moroccan Cannabis and hashish	63
Editorial Board	62
Editorial Board	61
Incarceration history, antiretroviral therapy, and stigma: A cross-sectional study of people with HIV who inject drugs in St. Petersburg, Russia	60
Editorial Board	58
Publisher's Note	55
Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States	54
Opioid agonist therapy engagement and crystal methamphetamine use: The impact of unregulated opioid use in Vancouver, Canada	53
Visitors of the Dutch drug checking services: Profile and drug use experience	52
Rethinking enhancement substance use: A critical discourse studies approach	48
Identifying how the principles of self-determination could be applied to create effective alcohol policy for First Nations Australians: Synthesising the lessons from the development of general public	48
A matter of craving–An archeology of relapse prevention in Swedish addiction treatment	48
Social-spatial network structures among young urban and suburban persons who inject drugs in a large metropolitan area	47
High HCV cure rates among people who inject drugs and have suboptimal adherence: A patient-centered approach to HCV models of care	47
The introduction of fentanyl on the US–Mexico border: An ethnographic account triangulated with drug checking data from Tijuana	47
Doing more with less: A proposal to advance cigarette packaging regulations in the United States	47
Leveraging pooled medical examiner records to surveil complex and emerging patterns of polysubstance use in the United States	45

Identifying barriers and enablers to opt-out hepatitis C virus screening in provincial prisons in Quebec, Canada: A multilevel, multi-theory informed qualitative study with correctional and healthcare	45
Enhancing equity-oriented care in psychedelic medicine: Utilizing the EQUIP framework	45
The social-structural contexts of cannabis consumption and harm reduction among young Nigerian women	42
Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts	42
Older age at smoking initiation predicts successful cessation in adults who smoke: A prospective study	42
Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers	41
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis	41
Increased solitary drug use during COVID-19: An unintended consequence of social distancing	40
Trends in the use of cannabis products in Canada and the USA, 2018 – 2020: Findings from the International Cannabis Policy Study	40
I don't even want to go to the doctor when I get sick now: Healthcare experiences and discrimination reported by people who use drugs, Arizona 2019	39
The war on drugs in Southeast Asia as ‘state vigilantism’	38
The impact of an easy access drug supply management policy law on the consumption and abuse of opioids in Catalonia: A population-based study	37
‘As for dignity and respect…. me bollix’: A human rights-based exploration of service user narratives in Irish methadone maintenance treatment	37
Cannabis industry lobbying in the Colorado state legislature in fiscal years 2010–2021	37
The hammer and the nail: The triple lock of methods, realities and institutional contexts in Australian research on nightlife violence	37
Editorial Board	36
Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities	36
A readiness assessment for the prevention of alcohol-related harm in West Africa: A new methodological approach to inform practice and policy	36
Does cannabis testing in the military drive synthetic cannabinoid use? Self-reported use motivations among justice-involved veterans	36
Big business: The private sector market for image and performance enhancing drug harm reduction in the UK	36
Utilising an access to care integrated framework to explore the perceptions of hepatitis C treatment of hospital-based interventions among people who use drugs	35
Psychosocial stress and methamphetamine use: A mixed-methods study of intersectional stigma and Aboriginal and Torres Strait Islander methamphetamine use	35
The practice and embodiment of “goofballs”: A qualitative study exploring the co-injection of methamphetamines and opioids	35
Societal costs of illegal drug use in Sweden	34
Cannabis reduction among adolescents as spillover from successful tobacco control	34
Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019–2020	33
Erratum regarding previously published papers	33
Harms to children from the financial effects of others’ drinking	33
How do patient, pharmacist and medication characteristics and prescription drug monitoring program alerts influence pharmacists' decisions to dispense opioids? A randomised controlled factorial experi	33
Applying a mutual capacity building model to inform peer provider programs in South Africa and the United States: A combined qualitative analysis	32
Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs	32
The harms of punishing substance use during pregnancy	32
Playing at the edges, navigating sexual boundaries, and narrating sexual distress; Practices and perspectives of sexuality and gender diverse people who use GHB	32
Buprenorphine dispensing before and after the April 2021 X-Waiver exemptions: An interrupted time series analysis	32
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study	32
State sanctioned killing in the name of drugs: Laws, practice and conflicting trends in Asia	31
Transnational alcohol corporations in Nigeria as commercial determinants of health: Implications for policy	31
Strategies for addressing needle debris: A scoping review of needle debris and discarded drug paraphernalia associated with substance use	29
Substance use among refugees in three Lebanese camps: A cross-sectional study	29
Putting tendencies and trajectories to work: useful tools for engaging with accounts of change and recovery?	29
A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic	28
Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel	28
Likelihood of using a harm reduction vending machine among rural people who inject drugs in Appalachian Kentucky	28
Your diagnosis will not protect you (and neither will academia): Reckoning with education and Dis-Ease	28
Changes in arrests following decriminalization of low-level drug possession in Oregon and Washington	28
‘Pretty in Pink’ and ‘Girl Power’: An analysis of the targeting and representation of women in alcohol brand marketing on Facebook and Instagram	27
Heavy burden of non-fatal overdose among people who inject drugs in San Francisco, 2022	27
Co-located Heroin Assisted Treatment within primary care: A preliminary analysis of the implications for healthcare access, cost, and treatment delivery in the UK	27
Higher methadone dose at time of release from prison predicts linkage to maintenance treatment for people with HIV and opioid use disorder transitioning to the community in Malaysia	27
Suboptimal uptake and placement of a mandatory alcohol pregnancy warning label in Australia	27

Consent and violence amongst men in the context of sexualised drug use: A systematic scoping review	27
Ethical justifications for safe supply interventions	27
High levels of all-cause mortality among people who inject drugs from 2018 to 2022	27
Spotting as a risk mitigation method: A qualitative study comparing organization-based and informal methods	27
Consumer protection in drug policy: The human rights case for safe supply as an element of harm reduction	26
COVID-19 economic impact payments and opioid overdose deaths	26
A qualitative study of a publicly funded pharmacy-dispensed naloxone program	26
Measuring drug policy evolution: A cross-country analysis	26
Comparing police use of drug detection dogs amongst injecting and non-injecting groups of people who regularly use drugs in Australia	26
Substance use prevention interventions for children and young people in Sub-Saharan Africa: A systematic review	26
Understanding overdose incidents in Canadian federal custody	26
Do Australians use the prescription pathway when using nicotine vaping products to quit smoking?	25
Drug transactions and the dark web: Public perceptions of the locational setting of offenders and support for drug policy outcomes	25
Low daily oral PrEP adherence and low validity of self-report in a randomized trial among PWID in Ukraine	25
“What I should be doing is harm reduction, if I'm doing my job right”: Engagement with harm reduction principles among prosecutors enacting drug policy reform in the United States	25
Heavy episodic drinking and HIV disclosure by HIV treatment status among People with HIV in IeDEA Cameroon	25
An examination of the role of changes in country-level leisure time internet use and computer gaming on adolescent drinking in 33 European countries	25
Vaccination coverage among people who inject drugs: A systematic review	25
Trends in young people accessing English alcohol treatment services: 2014 to 2023	25
How can communities influence alcohol licensing at a local level? Licensing officers’ perspectives of the barriers and facilitators to sustaining engagement in a volunteer-led alcohol harm reduction a	25
Becoming a nitrous oxide user on social media: Learning to maximise pleasures and minimise harms	25
Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO study	24
Editorial Board	24
Tackling the overdose crisis through unionization: A response to Rivera & Friedman (2024)	24
Editorial Board	24
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019”	24
The relationship between cryptomarket drug purchase, social networks and adverse drug events: A cross-sectional study	24
Minimum legal age laws and perceived access to cigarettes, e-cigarettes, and other substances among youth in Canada, England, and the United States: 2017-2021	24
Recreational cannabis excise taxation in the USA: Constructing a comparable tax measure for empirical analysis	24
Haven't I waited long enough? The role of wait times and subjective impairment in cannabis-related driving behavior	24
The impact of alcohol minimum unit pricing on people with experience of homelessness: Qualitative study	24
Editorial Board	24
Prevalence of comorbid substance use disorders among people with opioid use disorder: A systematic review & meta-analysis	23
Public support for reinvesting resources from enforcing drug possession to health-promoting alternatives: A nationally representative poll of adults in the United States	23
Assessing HIV and overdose risks for people who use drugs exposed to compulsory drug abstinence programs (CDAP): A systematic review and meta-analysis	23
Stronger, longer, better opioid antagonists? Nalmefene is NOT a naloxone replacement	23
Social and structural determinants of health associated with police violence victimization: A latent class analysis of female sex workers who use drugs in Kazakhstan	23
Interconnected influence: Unraveling purdue pharmaceutical's role in the global response to the opioid crisis	23
2S/LGBTQ+ youth substance use and pathways to homelessness: A photovoice study	23
Drugs, guns, and violent crime in California	23
Problematizing “patient stability” in opioid use disorder care: Flexible definitions, (in)flexible treatment	23
“Undisciplined” drinking, multi-sectoralism and political power: Examining problematisations in the Botswana alcohol policy	23
Drug use typology, demographic covariates, and associations with condomless anal sex: A latent class analysis among a U.S. national cohort of men who have sex with men	23
Municipal socioeconomic environment and recreational cannabis use in Mexico: Analysis of two nationally representative surveys	23
Access and care for people with opioid use disorder in U.S. skilled nursing facilities: A policy commentary	23
Psychedelic discourses: A qualitative study of discussions in a Danish online forum	23
Bereaved mothers’ engagement in drug policy reform: A multisite qualitative analysis	23
Effectiveness and implementability of state-level naloxone access policies: Expert consensus from an online modified-Delphi process	22
Slamsex as slow edgework: Sexualized drug use and harm reduction in post-AIDS Taiwan	22
Predictors of intentional fentanyl use: Market availability vs consumer demand	22
Cannabis legalization and changes in cannabis and tobacco/nicotine use and co-use in a national cohort of U.S. adults during 2017–2021	22
“Harm per litre” as a concept and a measure in studying determinants of relations between alcohol consumption and harm	22
The details of decriminalization: Designing a non-criminal response to the possession of drugs for personal use	22
Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study	22
The success rate of online illicit drug transactions during a global pandemic	21
Implementing a peer-supported, integrated strategy for substance use disorder care in an outpatient infectious disease clinic is associated with improved patient outcomes	21
The benefits and challenges of virtual SMART recovery mutual-help groups: Participant and facilitator perspectives	21
Editorial Board	21
The intersection of substance use stigma and anti-Black racial stigma: A scoping review	21
Standard THC units: A tool to benchmark cannabis-related driving risks	21
Exploring trauma and wellbeing of people who use drugs after witnessing overdose: A qualitative study	20
Cost-effectiveness of mass screening for Hepatitis C virus among all inmates in an Irish prison	20
Decisional considerations for methadone uptake in Kyrgyz prisons: The importance of understanding context and providing accurate information	20
We are the researched, the researchers, and the discounted: The experiences of drug user activists as researchers	20
Synergistic effects of exposure to multiple types of violence on non-fatal drug overdose among women who inject drugs in Indonesia	20
Naloxone cascade of care among people who regularly inject drugs in Australia, 2020–2022	20
Patients prefer free drug disposal options delivered by pharmacists at the point of care: Results of a decision tree analysis of a national factorial vignette panel survey	20
“It’s not just the hit itself”: the social practice of injecting drug use among gay and bisexual men in Australia	19
Editorial Board	19
Post-retirement enlightenment syndrome: Worthy of investigation	19
A pilot implementation study to scale-up methadone in incarcerated persons with opioid use disorder and retain them on treatment after release in Moldova	19
Beverage-specific consumption trends: A cross-country, cross-sectional comparison	19
Editorial Board	19
How medical are states’ medical cannabis policies?: Proposing a standardized scale	19
‘Keeping a lid on it’: Exploring ‘problematisations’ of prescribed medication in prisons in the UK	19
Characterizing changes in drug use behaviour following supply shortages of 5-MeO-DIPT, alkyl nitrites and new psychoactive substances among men living with HIV in Japan	19
Examining the association between trenbolone, psychological distress, and aggression among males who use anabolic-androgenic steroids	19
Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis	19
The importance of PEOPLE who use drugs within drug policy reform debates: Findings from the UK Drug Policy Voices online survey	18
Current regulations in context: Scraping Australia's online nitrous oxide market	18

Women's experiences in injectable opioid agonist treatment programs in Vancouver, Canada	18
The impacts of COVID-19 on structural inequities faced by people living with HIV who inject drugs: A qualitative study in St. Petersburg, Russia	18
Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit	18
The association between social capital and drug overdose mortality in the United States	18
Decline in youth drinking in high-income settings: Implications for public health in low-income countries	18
Through the wine glass: How biographical midlife transitions and women's affective interpretations interact with alcohol consumption	18
The Baltic and Nordic responses to the first Taliban poppy ban: Implications for Europe & synthetic opioids today	18
Beyond the smoke: Historical analysis of the revenue implications of state cigarette tax policies, 1989 to 2019	18
Performance and image enhancing drug interventions aimed at increasing knowledge among healthcare professionals (HCP): reflections on the implementation of the Dopinglinkki e-module in Europe and Aust	18
Corrigendum to ‘Substances from unregulated drug markets – A retrospective data analysis of customer-provided samples from a decade of drug checking service in Zurich (Switzerland)’ [Volume 114, April	17
Beyond a ‘post-cure’ world: Sketches for a new futurology of hepatitis C	17
Risk and enabling environments in sport: Systematic doping as harm reduction	17
Trends in cannabis use among U.S. adults amid the COVID-19 pandemic	17
Radical hospitality: Innovative programming to build community and meet the needs of people who use drugs at a government-sanctioned overdose prevention site in San Francisco, California	17
Adoption of methadone take home policy by U.S. state opioid treatment authorities during COVID-19	17
Holding ‘new recovery’ together: Organising relations and forms of coordination in professional sociomaterial practices of addiction recovery	17
Association between fatal opioid overdose and state medical cannabis laws in US national survey data, 2000-2011	17
Restrictive opioid prescribing policies and evolving risk environments: A qualitative study of the perspectives of patients who experienced an accidental opioid overdose	17
Digital localisation in an illicit market space: interactional creation of a psychedelic assemblage in a darknet community of exchange	17
Recovery as a minor practice	17
Substances from unregulated drug markets – A retrospective data analysis of customer-provided samples from a decade of drug checking service in Zurich (Switzerland)	17
Availability and use of non-prescribed buprenorphine-naloxone in a Canadian setting, 2014–2020	17
“I've lost my children to vaping”: A frame analysis of the Australian media's construction of the “Youth vaping crisis”	17
“It should be hard to be a drug abuser” An evaluation of the criminalization of drug use in Sweden	17
Reprint of: Biotechnologies and the future of opioid addiction treatments	17
Using a “Big Events” framework to understand emergency department use among women experiencing homelessness or housing instability in San Francisco during the COVID-19 pandemic	16
Decrease in provider stigma is associated with improved quality health indicators among individuals receiving methadone in primary care centers in Ukraine	16
Facilitating access to direct-acting antivirals in a community-based point-of-diagnosis model for hepatitis C treatment: The role of the pharmacy team in the no one waits (NOW) study	16
A call for compassionate opioid overdose response	16
Disentangling opioids-related overdose syndemics: a scoping review	16
An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study	16
Drug treatment and support service utilization amidst the COVID-19 pandemic among people who inject drugs in Baltimore, Maryland: An interrupted time-series analysis, 2015–2022	16
“There’s a lot of stereotypes going on”: A cross-national qualitative analysis of the place of gender in declining youth drinking	16
Association between U.S. state prenatal drug use laws and child welfare reporting in Alabama, Maryland and Utah	16
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial	16
Monitoring for fentanyl within Australian supervised injecting facilities: Findings from feasibility testing of novel methods and collaborative workshops	16
Voices represented and voices silenced: Represented voices in the media coverage of the implementation of a supervised injecting facility	16
Conceptualizing overdose trauma: The relationships between experiencing and witnessing overdoses with PTSD symptoms among street-recruited female sex workers in Baltimore, Maryland	16
Volatile substances are an amorphous category, making it hard to build a comprehensive body of research	16
The role of gifts in building influence with politicians: Thematic analysis of interviews with current and former parliamentarians	15
Impact of COVID-19 on the characteristics of opioid overdose deaths in Arkansas	15
Understanding challenges for recovery homes during COVID-19	15
Carfentanil on the darknet: Potential scam or alarming public health threat?	15
Unpacking the differing understandings of “alcohol industry” in public health research	15
Simulating the impact of Addiction Consult Services in the context of drug supply contamination, hospitalizations, and drug-related mortality	15
High and highly bonded: Fused football fans who use cocaine are most likely to be aggressive toward rivals	15
Post-Brexit opportunities for tobacco policy reform and tobacco harm reduction in the UK	15
Defining a public health approach to substance use: Perspectives from professionals and practitioners across Canada	15
‘I just drink to feel abnormal for some time’: Reconfiguring heavy drinking and intoxication as pleasurable	15
Analysis of gaps in alcohol policies in Brazil using the Pan American Health Organization's Alcohol Policy Scoring	15
Deadly serious: The United Nations, drugs, and capital punishment in the 1980s	14
Community-administered naloxone for overdose reversal: The role of sex worker-led programming and occupational violence in a community-based cohort (2018–2024)	14
Coordination, cooperation, and creativity within harm reduction networks in Iran: COVID-19 prevention and control among people who use drugs	14
Not just fentanyl: Understanding the complexities of the unregulated opioid supply through results from a drug checking service in British Columbia, Canada	14
The effectiveness of smoking cessation interventions in rural and remote populations: Systematic review and meta-analyses	14
Drug induced homicide laws may worsen opioid related harms: An example from rural North Carolina	14
Adherence to antiretroviral therapy among HIV positive men who inject drugs in Pakistan	14
From Anti-doping-I to Anti-doping-II: Toward a paradigm shift for doping prevention in sport	14
‘Some days I am a lunatic that thinks I can moderate’: Amalgamating recovery and neo-liberal discourses within accounts of non-drinking among women active in the ‘positive sobriety’ community on Insta	14
Policy actor views on structural vulnerability in harm reduction and policymaking for illegal drugs: A qualitative study	14
Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework	14
Socio-ecological and pharmacy-level factors associated with buprenorphine stocking at pharmacies in New York City	14
Where to next? An exploration of ‘night-out’ location progression and propensity to experience violence in night -time entertainment precincts	14
Drug policy goals in a changing landscape: Perspectives of practitioners in Japan	14
‘Red Flags’ and ‘Red Tape’: Telehealth and pharmacy-level barriers to buprenorphine in the United States	14
Can alcohol policy prevent harms to women and children from men's alcohol consumption? An overview of existing literature and suggested ways forward	14
Cognitive enhancing drug use by students in the context of neoliberalism: cheating? Or, a legitimate expression of competitive entrepreneurialism?	14
Long-term patterns of treatment use for opioid use disorder (OUD): Findings from the 18-20-year Australian Treatment Outcome Study	13
Exploring multiple drug use by integrating mobile health and qualitative mapping methods - An individual case study	13
Out of pocket expenses: effect of fee-waivers on opioid prescribing and dispensing	13
Unlocking deflection: The role of supervisor support in police officer willingness to refer people who inject drugs to harm reduction services	13
Public transport access to drug treatment before and during COVID-19: Implications for the opioid epidemic	13
Understanding the longitudinal relationship between substance use and violent victimization among street-based women who exchange sex in Baltimore, Maryland	13
Using synthetic controls to estimate the population-level effects of Ontario's recently implemented overdose prevention sites and consumption and treatment services	13
Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020	13
Towards equity for people who inject drugs in HIV prevention drug trials	13
Programmatic alcohol advertising, social media and public health: Algorithms, automated challenges to regulation, and the failure of public oversight	13
Stimulant-involved overdose deaths: Constructing dynamic hypotheses	13
Addressing the complex substance use and mental health needs of people leaving prison: Insights from developing a national inventory of services in Canada	13
Factors associated with attending “open bar” parties amongst early adolescents	13
“Apparently, you can only be treated once”: A qualitative study exploring perceptions of hepatitis C and access to treatment among people who inject drugs visiting a needle and syringe program	13
Are dietary supplement users more likely to dope than non-users?: A systematic review and meta-analysis	13
Are recreational cannabis laws associated with declining medical cannabis program enrollment in the U.S.? An analysis of cardholder enrollment and demographic characteristics from 2013 to 2020	13
Editorial Board	13
Connecting patients notified with hepatitis C to treatment (CONNECT Study): A randomized controlled trial of active case management by a health department to support primary care practitioners	13
The emerging norms of e-cigarette use among adolescents: A meta-ethnography of qualitative evidence	13
‘I just thought that was the best thing for me to do at this point’: Exploring patient experiences with depot buprenorphine and their motivations to discontinue	13
Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study	13
Alcohol policy changes during the first three-months of the COVID-19 pandemic: Development and application of a classification scheme	13
Political constructions of people who use drugs in the Philippines: A qualitative content analysis	12
Assisted injection provider practices and motivations in Los Angeles and San Francisco California 2016–18	12
“Another tool in the toolkit”—Perceptions, suggestions, and concerns of emergency service providers about the implementation of a supervised consumption site	12
Multilevel determinants of cannabis prices in legal markets: Evidence from products sold in nearly 4000 cannabis dispensaries in the United States	12
Reimbursing incarcerated individuals for participation in research: A scoping review	12
Editorial Board	12